Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.

Biliary Obstruction
Authors

Ethan M. Coucke1; Hina Akbar2; Arslan Kahloon3; Peter P. Lopez4.

Affiliations
1 McLaren Health Care
2 University of Tennessee Health Sciences Center
3 University of Tennessee, Chattanooga
4 MSU

Last Update: November 26, 2022.

Continuing Education Activity

Biliary obstruction refers to the impairment of bile flow from the liver to the small intestine due to blockage of the
biliary duct system. Bile obstruction affects a large portion of the population around the world, with significant
morbidity and mortality. The most common etiology of biliary obstruction is gallstones causing common bile duct
obstruction, which manifests as pain, nausea/vomiting, and jaundice. This activity describes the etiology,
pathophysiology, evaluation, and management of biliary obstruction and highlights the interprofessional team's role in
caring for affected patients.

Objectives:

Describe the pathophysiology of biliary obstruction.

Outline the evaluation in patients with biliary obstruction.

Explain the treatment options available for patients with biliary obstruction.

Describe the significance of a coordinated interprofessional team in the early evaluation and management of
patients with biliary obstruction.

Access free multiple choice questions on this topic.

Introduction
Biliary obstruction commonly refers to blockage of the bile duct system leading to impaired bile flow from the liver
into the intestinal tract. Bile is a substance that contains bile salts, bilirubin, and cholesterol and is continuously
synthesized in the liver hepatocytes. Bile is then transported via the bile ducts into the second portion of the duodenum
to assist with the metabolism of fats.[1]

Bile formed in the liver flows through the right and left hepatic ducts into the common hepatic duct. The common
hepatic duct then joins the cystic duct arising from the gallbladder to form the common bile duct. The common bile
duct then joins the pancreatic duct through its course within the head of the pancreas before opening into the duodenum
through the major papilla or ampulla. The majority of the bile flows into the gall bladder through the cystic duct, where

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 1 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

it is concentrated and temporarily stored, while the rest of the bile flows through the common bile duct into the
duodenum through the sphincter of Oddi. The flow of bile into the duodenum is regulated by the release of the
hormone Cholecystokinin (CCK) from the duodenum, which controls the release of stored bile from the gallbladder
and the relaxation of the sphincter of Oddi.

Biliary obstruction is generally referred to as blockage of the extrahepatic biliary system. Biliary obstruction can occur
anywhere along this path and can lead to serious complications such as hepatic dysfunction, renal failure, nutritional
deficiencies, bleeding problems, and infections.[2]

Disruption in the bile flow due to impairment of the intrahepatic biliary system is generally referred to as cholestasis.
Cholestasis can present as abnormalities in serum hepatic enzymes, such as elevated bilirubin and alkaline phosphatase
levels, and can lead to jaundice and pruritis.

Biliary obstruction is common and affects a large portion of the world population, causing significant morbidity and
mortality. The most common etiology of biliary obstruction is choledocholithiasis or gallstones, causing extrahepatic
bile duct blockage. The most serious manifestation of this is the development of infection in the bile ducts called
cholangitis, which can be fatal if not treated promptly.[3]

Etiology
Biliary obstruction can be divided into intrahepatic and extrahepatic etiologies. As described above, intrahepatic biliary
obstruction is generally called cholestasis and is not covered here in detail as it is not the scope of this topic. Briefly,
intrahepatic cholestasis can be from several disease processes, including certain forms of hepatitis (viral infections,
alcohol), drug-induced liver injury (antibiotics, acetaminophen, anti-epileptics, anti-arrhythmic), primary biliary
cholangitis, primary sclerosing cholangitis, and infiltrative diseases (sarcoidosis, tumors, abscess, and cysts).[4][5]

Extrahepatic biliary obstruction, which is the scope of this article, can be divided into various benign and malignant
etiologies. These include choledocholithiasis (gall stones in the common bile duct), choledochal cysts (dilation/cysts of
bile ducts), Mirizzi syndrome (gall stones in cystic duct pressing on bile duct), benign structuring diseases like Primary
sclerosing cholangitis (PSC), fibrotic strictures from gall stone passage or iatrogenic strictures from bile duct
cannulation. Neoplastic stricture diseases causing biliary obstruction can include cholangiocarcinoma (bile duct
cancer), pancreatic head cancer leading to distal common bile duct stricture, and ampullary carcinoma or adenoma.
Other etiologies of biliary obstruction can include infectious diseases like parasitic cholangiopathy (Clonorchis
sinensis, Ascaris lumbricoides) causing intra- or extrahepatic obstruction to bile flow, inflammatory and autoimmune
diseases like AIDS cholangiopathy, and autoimmune cholangiopathy.[6]

Epidemiology
The incidence of gallstones causing biliary obstruction is approximately 5 in 1000 people, whereas 10% to 15% of the
adult U.S. population will develop gallstones in their lifetime.[6] Gallstones or Cholelithiasis, including gall bladder
sludge formation, is the precursor of choledocholithiasis, where gallstones pass through the cystic duct and get lodged
into the common hepatic ducts causing an obstruction. Between 10 and 15% of patients with gallstones are also noted
to have common bile duct stones at diagnosis.[7]

Women are at greater risk of developing gallstones than men and hence increased risk for choledocholithiasis. This is
likely secondary to estrogen increasing hepatic uptake of cholesterol, which increases bile production and some degree
of cholestasis.[8]

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 2 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Gallstones are the most common cause of biliary obstruction in Hispanics, Northern Europeans, and Native Americans.
Northern Native Americans have the highest reported rates of cholelithiasis at 64% for females and 29% for males.
Asian and African Americans have an intermediate prevalence of cholelithiasis, with 13.9% in women and 5.3% in
men. The lowest prevalence of cholelithiasis is in sub-Saharan Black Africa, with an overall prevalence of less than
5%. White race North Americans have an overall prevalence of cholelithiasis of 16.6% and 8.6% in females and males,
respectively.[9][8]

In developed countries, choledocholithiasis secondary to cholesterol stones is the most common cause of biliary
obstruction, whereas brown pigment stones from infectious etiologies or hemolysis are the most common etiology in
Asia. Other etiologies like recurrent pyogenic cholangiohepatitis are characterized by recurrent bacterial cholangitis,
dilatation, and stricture of the biliary tree, the presence of calculi within the intrahepatic bile ducts, and an increased
risk for cholangiocarcinoma is common in Asia but rare in the west. Gallbladder malignancy is more common in
Central and South America, Central and Eastern Europe, the northern Indian subcontinent, and East Asia.[10][11][8]

Pathophysiology
1. Catabolism of hemoglobin is a normal function that releases heme molecules, which then converts to biliverdin,
a precursor to bilirubin. Biliverdin then transforms into unconjugated bilirubin within the
reticuloendothelial system. Being that unconjugated bilirubin is lipid-soluble, the renal system does not eliminate
it. Unconjugated bilirubin is bound in serum to albumin or exists as free unbound bilirubin. Unbound bilirubin is
taken up by hepatocytes and converted to conjugated bilirubin, which is water-soluble. Conjugated bilirubin
becomes part of the bile, which is secreted from the hepatocytes in the liver.

2. Bile formed in the liver flows through the right and left hepatic ducts into the common hepatic duct. Fifty percent
of the bile flows into the cystic duct and is then stored in the gallbladder, with the rest of the bile flowing through
the common bile duct and converging and flowing through the main pancreatic duct in the head of the pancreas
to empty into the duodenum through the sphincter of Oddi.

3. Biliary obstruction refers to obstruction in the biliary system, leading to blockage of bile flow into the small
intestine. Biliary obstruction can occur anywhere along the path from the liver to the intestinal tract. Biliary
obstruction is common and affects a large portion of the population around the world, with significant morbidity
and mortality. Gallstones are the most prevalent cause of biliary obstruction; they commonly manifest by
dilatating the common bile duct and jaundice.

4. Jaundice, a physical exam finding of yellowish discoloration of the skin, conjunctiva, and/or mucous
membranes, is a consequence of obstruction leading to bile stasis and buildup of conjugated bilirubin in the
blood.

5. Normal total serum bilirubin values are 0.2 to 1.2 mg/dL. Jaundice is evident clinically at the level of 3 mg/dl.

6. Normal urine contains no bilirubin; however, in patients with obstructive jaundice, conjugated bilirubin is
excreted in the urine, giving it a dark color. Urinary bilirubin is detectable at a lower level of bilirubin than that
needed to cause clinical jaundice.

7. The inability of bilirubin to reach the intestinal tract gives pale color to stools.

8. Pruritus is common in patients with biliary obstruction, but the cause of this is unknown. The deposition of bile
acid into the skin is one postulation that could account for these symptoms. Percutaneous biliary drainage was

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 3 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

found to decrease pruritis symptoms.[12]

Histopathology
Intrahepatic cholestasis can be diagnosed with a percutaneous or transjugular liver biopsy and is not covered in detail
under this topic.

Extrahepatic biliary obstruction can also lead to chronic changes to liver histology over prolonged obstruction of bile
ducts. However, the etiology of biliary obstruction can be determined through histology from brush cytology or tissue
biopsy samples obtained during various procedures like endoscopic retrograde cholangiopancreatography
(ERCP), percutaneous transhepatic cholangiogram (PTC), or endoscopic ultrasound (EUS) directed biopsy. Sometimes
a tissue sample is imperative for accurate diagnosis, especially for the workup for stricture of the biliary tract noted on
non-invasive imaging.

History and Physical

History and Presentation

Biliary obstruction can have very varied presentations depending on the underlying etiology. It usually presents as
jaundice with clay-colored or acholic stools and dark urine. Patients can have pruritis with chronic biliary obstruction.
Patients depending on underlying etiology, can have right upper quadrant abdominal pain, fever, nausea and vomiting,
and weight loss. The onset of these symptoms can be variable ranging from acute development of symptoms to over
months.

A careful history of symptom duration, if gradual or acute onset, accompanying symptoms like weight loss, loss of
appetite, nausea/vomiting is important. Similarly, any right-sided abdominal pain, along with severity and radiation, is
important to know. History of diarrhea, hematochezia, and upper GI bleeding symptoms is also relevant to diagnosing
the underlying process. It is imperative to know any pertinent personal and family history like bile duct or pancreatic
malignancy, inflammatory bowel disease, or primary liver disease. A careful review of social history related to current
and former smoking, alcohol use, and drug abuse is important. Similarly, travel history to parasitic endemic regions is
of value in determining the etiology of biliary obstruction. A careful review of medication history can sometimes be of
great significance in determining intrahepatic cholestasis vs. extrahepatic biliary obstruction.

Physical Examination

A detailed and thorough physical exam is of paramount importance. It is imperative to check baseline vital signs,
especially checking for fever and elevated heart rate. A general physical exam to assess for any distress, pallor, skin
jaundice, scleral icterus, palmer erythema, and signs of malnutrition is important. A detailed abdominal examination to
assess for right upper quadrant tenderness (Murphy's sign), hepatomegaly and splenomegaly, presence of ascites, any
palpable mass, and stigmata of cirrhosis (caput-medusae) is very crucial for diagnosis. A cardiac exam to assess for
signs of congestive heart failure with jugular venous distension and displacement of heart sounds can be very important
to determine underlying etiology. Similarly, a pulmonary exam to assess for pleural effusions, determining whether
one-sided or bilateral, helps determine etiology. Assessment for lymphadenopathy in left supraclavicular lymph nodes
and other neck lymph nodes can provide helpful information. Looking for lower extremity edema is also important.

Evaluation
Blood Tests [13] [14]

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 4 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Workup for biliary obstruction includes routine labs and some dedicated labs, including:

Complete blood count (CBC)

Comprehensive metabolic profile (CMP)

Fractionated bilirubin

Alkaline phosphatase and fractionation

Gamma-glutamyltransferase

Viral hepatitis serology

Antimitochondrial antibody levels

Antinuclear antibody

Coagulation studies

Tumor markers (CA19-9, CEA, AFP)

Urine Test

Urine bilirubin

Stool Test

Occult blood to rule out GI malignancy

Radiological and Endoscopic tests - Non-invasive and invasive radiologic tests can help diagnose the underlying
etiology of biliary obstruction.[15][16]

Abdominal ultrasound with Doppler can be a starting radiological test due to its low cost, non-invasive test, and
easy availability. Ultrasound is a good test to evaluate gallstones, dilations of extrahepatic bile ducts, and assess
for patency of blood vessels using doppler.

Based on the ultrasound results, an abdominal CT scan can be the next step. This can help assess for pancreatic
head lesions and liver lesions and rule out other intra-abdominal processes.

Nuclear medicine scans like the HIDA scan can assess for cystic duct obstruction.

MRCP (magnetic resonance cholangiopancreatography) is a very sensitive test to assess further intra- and
extrahepatic bile duct abnormalities like cholangiocarcinoma, strictures, or bile duct stones.

Endoscopic tests like EUS (endoscopic ultrasound) with needle aspiration and ERCP with cytology and biopsies
can be further considered based on noninvasive testing results. ERCP can be both diagnostic and therapeutic in
cases of biliary obstruction caused by gallstones.

Sometimes interventional radiology-based PTCA (percutaneous transhepatic cholangiogram) can be done to

obtain biopsies and evaluate for strictures.

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 5 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Treatment / Management
Initial Management

Initial management depends on the patient's clinical condition and probable etiology. If the patient is stable, most of the
work can be done as an outpatient with regular follow-ups in the gastroenterology clinic. However, if the patient is
febrile and showing signs of sepsis and hepatic dysfunction, admitting the patient for evaluation and treatment may be
necessary. This is needed in patients with acute cholangitis, cholecystitis, and acute liver failure.

Treatment [17]

Treatment varies widely depending on the etiology of biliary obstruction. Some common etiologies and board
management are discussed below.

Cholelithiasis and Choledocholithiasis [18] [19]

Gallstones with common bile duct (CBD) stones;

CBD size less than 1.5cm with small stones- ERCP and sphincterotomy with cholecystectomy

CBD size more than 1.5cm with large stones - ERCP and sphincterotomy with lithotripsy,
choledochotomy, choledochoduodenostomy, choledochojejunostomy, or cholecystectomy

CBD Stricture [20]

Benign

Endoscopic sphincterotomy and balloon dilatation

Endoscopic stenting with stent removal/exchange at 4 to 6 weeks

Biliary-enteric bypass if and when surgery is required

Malignant

Endoscopic drainage with stenting

Percutaneous drainage with PTC with internal and external drainage

Palliative biliary-enteric bypass in unresectable cases

Resection of the tumor with biliary-enteric anastomosis in resectable disease

Parasites [21] [22]

Medication

Albendazole

Mebendazole

Pyrantel pamoate

Surgical/endoscopic:

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 6 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

ERCP with sphincterotomy and extraction using a basket.

In the case of gallbladder invasion, cholecystectomy, CBD exploration, and T-tube placement

Choledochal Cysts [23]

Assessment for malignancy with ERCP and cytology

Possible Excision and hepaticojejunostomy if required

Neoplasm [24]

Advanced disease

Palliation with endoscopic biliary stenting and chemoradiotherapy or photodynamic therapy

Percutaneous transhepatic endobiliary radiofrequency ablation along with biliary stenting

Duodenal stenting in ampullary carcinoma

Resectable disease

Excision with clear margins and bilioenteric anastomosis

Pancreatic head carcinoma

Whipple procedure/pylorus-preserving pancreaticoduodenectomy

Ampullary carcinoma

Whipple procedure

Gallbladder malignancy

Cholecystectomy with liver resection and lymph node clearance

Differential Diagnosis
The differential diagnosis for biliary obstruction is very broad, ranging from benign disease to malignant diseases, as
mentioned below.

Benign Diseases [25]

Acute cholecystitis and biliary colic from gallstones (cholelithiasis)

Acute pancreatitis

Alcoholic hepatitis

Ascariasis

Bile duct strictures and cholangitis

Biliary trauma and leaks

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 7 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Choledochal cysts

Chronic pancreatitis

Cirrhosis from various etiologies

Viral hepatitis, including chronic hepatitis B and hepatitis C

Hepatocellular adenoma and carcinoma

Mirizzi syndrome

Primary biliary cholangitis

Primary sclerosing cholangitis

Malignant Diseases

Ampullary carcinoma or adenoma

Bile duct tumors (cholangiocarcinomas)

Gallbladder cancer

Pancreatic cancer

Primary hepatic malignancies

Enlarged malignant lymph nodes

Prognosis
The prognosis of biliary obstruction is highly dependent on the etiology. If left untreated, it can lead to life-threatening
infection and sepsis. If the obstruction is persistent and chronic, it is usually due to a chronic liver pathology, which
commonly has a poor prognosis. Most acute cases can be successfully managed with medical, surgical, and/or
endoscopic treatment with full recovery. Obstruction caused by chronic liver disease and malignant etiology usually
has a less favorable prognosis.

Complications
Acute Cholangitis

One of the most feared complications of biliary obstruction is acute ascending cholangitis, which is an infection of the
biliary tree due to obstruction, which can quickly lead to systemic sepsis and resultant multi-organ failure.

Acute cholangitis can present as Charcot’s triad (right upper quadrant pain, fever, and jaundice) or Reynold’s pentad
(Charcot's triad with mental status change and hemodynamic shock). Important and helpful laboratory evaluation
includes elevated White blood cell count with leukocytosis, Abnormal liver testing with elevated bilirubin levels,
alkaline phosphatase, and gamma-glutamyl transpeptidase. Elevation of bilirubin is generally in the form of conjugated
hyperbilirubinemia.

Important diagnostic tests include abdominal ultrasound, CT scan of the abdomen, and MRCP.

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 8 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Severe cases of cholangitis present with[26]:

Hypotension requiring any vasopressor

Mental status change

PaO2/FiO2 less than 300

Serum creatinine greater than 2.0 mg/dL

INR greater than 1.5

Platelet count less than 100000/mm^3

Treatment

General Principles

Initial management for acute cholangitis requires admission to the hospital for IVF resuscitation and electrolyte
replacement, pain control, and antibiotics with activity against enteric streptococci, coliforms, and anaerobes are
generally needed.

Low-risk community-acquired infections can be treated with ertapenem or piperacillin-tazobactam or

combination therapy like ceftriaxone, ciprofloxacin, or levofloxacin with metronidazole.

High-risk community-acquired infections can be treated with imipenem-cilastatin, meropenem, or piperacillin-

tazobactam or combination therapy such as cefepime or ceftazidime with metronidazole.

Drainage ProceduresMost patients with cholangitis will eventually require one of the following:

Decompression procedure with ERCP (endoscopic retrograde cholangiopancreatography)

Endoscopic removal of biliary stones with drainage of bile, often with sphincterotomy, PTC (percutaneous
transhepatic cholangiography)

Insertion of a needle into the biliary tract percutaneously for drainage, removal of stones, and possible placement
of the biliary stent or surgical drainage

Open or laparoscopic surgical intervention with biliary decompression, removal of the obstruction, and
cholecystectomy if warranted and the patient is stable

Consultations
Biliary obstruction can result from various etiologies, which could be complex and considered difficult to access
anatomy; its management may require a multi-specialty approach, including:

Gastroenterology and hepatology

Radiology

Interventional radiology

Pathology

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 9 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Oncology

General or hepatobiliary surgery

Deterrence and Patient Education

Biliary Obstruction

Blockage within the biliary tract leads to obstruction of bile flow to the small intestine.

Most Common Cause

Gallbladder stones that can obstruct the biliary tract

Symptoms

Right upper quadrant abdominal pain

Pain in the back under the shoulder blade

Nausea and vomiting

Jaundice (yellowing of the skin)

Testing

Laboratory evaluation and imaging

Ultrasound of the abdomen

Further testing will be chosen appropriately depending on the results of the initial testing.

Treatment

Treatment for biliary obstruction depends on the cause but likely will be either surgical or non-surgical,
including endoscopic.

Surgical may include cholecystectomy to remove the gallbladder if the cause is gallstones, along with ERCP
with sphincterotomy to remove any gallstones from the biliary tract causing an obstruction.

Non-surgical may include stabilization and pain control along with medications to help dissolve any gallstones
causing an obstruction.

Patients should eat a low-fat, high-fiber diet. They should avoid fried foods, canned fish, processed meats, full-
fat dairy products, processed baked goods, fast food, and most packaged snack foods. whole fruits and
vegetables high in vitamin C, like kiwi and broccoli. citrus fruits, like orange and grapefruit, may be beneficial.

Prevention of Recurrence

Maintain a healthy body weight with proper nutrition and exercise

Enhancing Healthcare Team Outcomes

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 10 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Biliary obstruction encompasses many separate conditions that result in a typical clinical finding of elevated bilirubin.
Patients may first present to their primary care physicians, nurse practitioners, or an emergency department for
treatment. A prompt initial diagnosis helps drive therapy and improve outcomes in most patients. Special attention is
necessary for timely diagnosis of infection of the bile ducts where patients present with fever, sepsis, and biliary
obstruction findings, which can lead to poor prognosis. Initial laboratory and radiographic assessment will determine
the proper specialty needed to treat the obstruction, whether general surgery, gastroenterology, oncology, or
interventional radiology.

Management of biliary obstruction requires the efforts of an interprofessional healthcare team comprised of clinicians
(including PAs and NPs), specialists, nurses, and pharmacists, all collaborating and communicating across disciplinary
boundaries to achieve improved patient outcomes. [Level 5]

Review Questions
Access free multiple choice questions on this topic.

Comment on this article.

References
1. Hundt M, Basit H, John S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 26, 2022.
Physiology, Bile Secretion. [PubMed: 29262229]
2. Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management.
Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):17-21. [PubMed: 29428098]
3. Kruis T, Güse-Jaschuck S, Siegmund B, Adam T, Epple HJ. Use of microbiological and patient data for choice of
empirical antibiotic therapy in acute cholangitis. BMC Gastroenterol. 2020 Mar 12;20(1):65. [PMC free article:
PMC7066745] [PubMed: 32164573]
4. Siddiqui AI, Ahmad T. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jan 8, 2023. Biliary
Atresia. [PubMed: 30725947]
5. Kamal F, Williams G, Akbar H, Khan MA, Kadaria D. Klebsiella Pneumoniae Liver Abscess: a Case Report and
Review of Literature. Cureus. 2017 Jan 10;9(1):e970. [PMC free article: PMC5298907] [PubMed: 28191374]
6. Taylor T, Wheatley M, Gupta N, Nusbaum J. Jaundice in the emergency department: meeting the challenges of
diagnosis and treatment [digest]. Emerg Med Pract. 2018 Apr 02;20(Suppl 4):1-2. [PubMed: 29634896]
7. Zhang W, Wang BY, Du XY, Fang WW, Wu H, Wang L, Zhuge YZ, Zou XP. Big-data analysis: A clinical pathway
on endoscopic retrograde cholangiopancreatography for common bile duct stones. World J Gastroenterol. 2019 Feb
28;25(8):1002-1011. [PMC free article: PMC6397721] [PubMed: 30833805]
8. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010
Jun;39(2):157-69, vii. [PubMed: 20478480]
9. Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. Eur J Clin Invest. 2018 Jul;48(7):e12935.
[PubMed: 29635711]
10. Njeze GE. Gallstones. Niger J Surg. 2013 Jul;19(2):49-55. [PMC free article: PMC3899548] [PubMed:
24497751]
11. Verweij KE, van Buuren H. Oriental cholangiohepatitis (recurrent pyogenic cholangitis): a case series from the
Netherlands and brief review of the literature. Neth J Med. 2016 Nov;74(9):401-405. [PubMed: 27905307]
12. Heedman PA, Åstradsson E, Blomquist K, Sjödahl R. Palliation of Malignant Biliary Obstruction: Adverse Events

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 11 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

are Common after Percutaneous Transhepatic Biliary Drainage. Scand J Surg. 2018 Mar;107(1):48-53. [PubMed:
28946806]
13. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab
Sci. 1980;12(1):1-58. [PubMed: 6104563]
14. Schiff ER. Cholestatic evaluation. Lab Res Methods Biol Med. 1983;7:517-28. [PubMed: 6353112]
15. Wyatt SH, Fishman EK. Biliary tract obstruction. The role of spiral CT in detection and definition of disease. Clin
Imaging. 1997 Jan-Feb;21(1):27-34. [PubMed: 9117928]
16. Padilla RM, Hulsberg PC, Soule E, Harmon TS, Eadie E, Hood P, Shabandi M, Matteo J. Against the Odds: A
Novel Technique to Perform Cholangiography from a Percutaneous Approach through the Cystic Duct. Cureus.
2018 Nov 12;10(11):e3577. [PMC free article: PMC6333255] [PubMed: 30656081]
17. Sarin SK, Choudhury A. Management of acute-on-chronic liver failure: an algorithmic approach. Hepatol Int.
2018 Sep;12(5):402-416. [PubMed: 30116993]
18. Della Penna A, Lange J, Hilbert J, Archid R, Königsrainer A, Quante M. Ursodeoxycholic Acid for 6 Months
After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic
Gallstones. Obes Surg. 2019 Apr;29(4):1216-1221. [PubMed: 30604076]
19. Nabi Z, Reddy DN. Endoscopic Management of Combined Biliary and Duodenal Obstruction. Clin Endosc. 2019
Jan;52(1):40-46. [PMC free article: PMC6370931] [PubMed: 30626177]
20. Beyna T, Gerges C. Clinical Management of Bile Duct Diseases: Role of Endoscopic Ultrasound in a
Personalized Approach. J Pers Med. 2020 Dec 22;11(1) [PMC free article: PMC7821935] [PubMed: 33374902]
21. Yılmaz S, Akıcı M, Şimşek M, Okur N, Erşen O, Tuncer AA. Endoscopic retrograde cholangiopancreatography
for biliary system parasites. Turk J Surg. 2018 Jan 03;34(4):306-310. [PMC free article: PMC6340658] [PubMed:
30664430]
22. Sharma M, Somani P. EUS of pancreatic ascariasis. Arab J Gastroenterol. 2018 Mar;19(1):47-48. [PubMed:
29523472]
23. Friedmacher F, Ford KE, Davenport M. Choledochal malformations: global research, scientific advances and key
controversies. Pediatr Surg Int. 2019 Mar;35(3):273-282. [PubMed: 30406431]
24. Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K,
Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki
K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Clinical practice
guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat
Sci. 2021 Jan;28(1):26-54. [PubMed: 33259690]
25. Clemente G, Tringali A, De Rose AM, Panettieri E, Murazio M, Nuzzo G, Giuliante F. Mirizzi Syndrome:
Diagnosis and Management of a Challenging Biliary Disease. Can J Gastroenterol Hepatol. 2018;2018:6962090.
[PMC free article: PMC6109484] [PubMed: 30159303]
26. Janmohamed A, Trivedi PJ. Patterns of disease progression and incidence of complications in primary biliary
cholangitis (PBC). Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:71-83. [PubMed: 30343713]
Disclosure: Ethan Coucke declares no relevant financial relationships with ineligible companies.

Disclosure: Hina Akbar declares no relevant financial relationships with ineligible companies.

Disclosure: Arslan Kahloon declares no relevant financial relationships with ineligible companies.

Disclosure: Peter Lopez declares no relevant financial relationships with ineligible companies.

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 12 de 13
Biliary Obstruction - StatPearls - NCBI Bookshelf 20/08/23 12:12

Copyright © 2023, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) (
http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used
commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK539698 PMID: 30969520

https://www.ncbi.nlm.nih.gov/books/NBK539698/?report=printable Página 13 de 13